图书馆订阅: Guest
真核基因表达评论综述™

每年出版 6 

ISSN 打印: 1045-4403

ISSN 在线: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Therapeutic Intervention with Breast Cancer Metastasis

卷 12, 册 2, 2002, 14 pages
DOI: 10.1615/CritRevEukaryotGeneExpr.v12.i2.40
Get accessGet access

摘要

Metastatic disease, mainly to the lungs, liver, bone, and brain, is the most common cause of death from breast cancer, despite advances in surgical and clinical management. Two basic principles govern the process of metastasis. First, that tumors are heterogeneous populations of cells, and second, that the process is a sequence of events that depends on tumor cell properties and interactions with the microenvironment at the site of metastasis. Inhibitors targeted at any of these different steps have the potential to inhibit metastatic progression, and examples of key therapeutic targets include overexpression of growth factor receptors, angiogenic factors, matrix metalloproteases, and integrin receptors. The identification of molecular targets for therapy of breast cancer metastasis will be accelerated by DNA array technology, and their selection for use should include evaluation of interactions between tumor cells and normal tissue components. These sorts of inhibitors are likely to target both cancer and normal cell functions, for example, inhibitors of matrix metalloproteases that can potentially inhibit both tumor cell invasion and angiogenesis. The use of appropriate animal models will be necessary to determine the impact of targeted inhibitors on the growth and development of breast cancer metastasis.

对本文的引用
  1. Rabbani Shafaat A., Mazar Andrew P., Evaluating distant metastases in breast cancer: from biology to outcomes, Cancer and Metastasis Reviews, 26, 3-4, 2007. Crossref

  2. Dréau Didier, Karaa Amel, Culberson Cathy, Wyan Heather, McKillop Iain H., Clemens Mark G., Bosentan® inhibits tumor vascularization and bone metastasis in an immunocompetent skin-fold chamber model of breast carcinoma cell metastasis, Clinical & Experimental Metastasis, 23, 1, 2006. Crossref

  3. Zhao Caijie, Cai Mi, Zhang Yao, Liu Ying, Sun Ronghua, Zhang Ning, Development of a microscopy-based assay for protein kinase Cζ activation in human breast cancer cells, Analytical Biochemistry, 362, 1, 2007. Crossref

  4. Clines Gregory A., Chirgwin John M., Guise Theresa A., Skeletal Complications of Malignancy: Central Role for the Osteoclast, in Bone Resorption, 2, 2005. Crossref

  5. Parker Belinda S., Eckhardt Bedrich L., Anderson Robin L., Models of Breast Cancer Metastasis to Bone: Characterization of a Clinically Relevant Model, in Bone Metastasis and Molecular Mechanisms, 6, 2004. Crossref

  6. Chhichholiya Yogita, Suman Prabhat, Singh Sandeep, Munshi Anjana, The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies, Medical Oncology, 38, 8, 2021. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain